A survey of opioid treatment programs finds that the proportion offering on-site testing for human immunodeficiency virus (HIV) and sexually transmitted infections (STIs) declined substantially between 2000 and 2011, despite guidelines recommending routine opt-out HIV testing in all health care settings, according to a study appearing in the Dec. 25 issue of JAMA.
Fuente : http://www.eurekalert.org/pub_releases/2013-12/tjn...
Fuente : http://www.eurekalert.org/pub_releases/2013-12/tjn...